Achillion Pharmaceuticals (ACHN) Weakness is a Buying Chance - Analyst
Go back to Achillion Pharmaceuticals (ACHN) Weakness is a Buying Chance - Analyst| Abbott Laboratories (NYSE: ABT) | Delayed: 106.89 -0.7 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.59 | 52 Week High | $46.38 | |||
| Open | $106.71 | 52 Week Low | $36.00 | |||
| Day High | $107.11 | P/E | 71.26 | |||
| Day Low | $105.56 | EPS | $1.50 | |||
| Volume | 5,052,723 | |||||
| Achillion Pharmaceuticals, Inc. (AMEX: ACHN) | Delayed: 0.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.79 | 52 Week High | $10.95 | |||
| Open | $0.79 | 52 Week Low | $3.78 | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.79 | EPS | $-0.63 | |||
| Volume | 500 | |||||
